These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 1891788)

  • 1. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial.
    Oksanen K; Kekomäki R; Ruutu T; Koskimies S; Myllylä G
    Transfusion; 1991 Sep; 31(7):588-94. PubMed ID: 1891788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial.
    van Marwijk Kooy M; van Prooijen HC; Moes M; Bosma-Stants I; Akkerman JW
    Blood; 1991 Jan; 77(1):201-5. PubMed ID: 1984797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancy.
    Blundell EL; Pamphilon DH; Fraser ID; Menitove JE; Greenwalt TJ; Snyder EL; Repucci AJ; Hedberg SL; Anderson JK; Buchholz DH; Kagen LR; Aster RH
    Transfusion; 1996 Apr; 36(4):296-302. PubMed ID: 8623127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte-depleted blood components prevent platelet refractoriness in patients with acute myeloid leukemia.
    Oksanen K
    Eur J Haematol; 1994 Aug; 53(2):100-7. PubMed ID: 8088380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.
    Sintnicolaas K; van Marwijk Kooij M; van Prooijen HC; van Dijk BA; van Putten WL; Claas FH; Novotny VM; Brand A
    Blood; 1995 Feb; 85(3):824-8. PubMed ID: 7833483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of refractoriness and HLA-alloimmunization using filtered blood products.
    Sniecinski I; O'Donnell MR; Nowicki B; Hill LR
    Blood; 1988 May; 71(5):1402-7. PubMed ID: 3282572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
    Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
    Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical aspects of platelet transfusions.
    Murphy MF; Waters AH
    Blood Coagul Fibrinolysis; 1991 Apr; 2(2):389-96. PubMed ID: 1893071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of pathogen-reduced platelet transfusions on HLA alloimmunization in hemato-oncological patients.
    Saris A; Kerkhoffs JL; Norris PJ; van Ham SM; Ten Brinke A; Brand A; van der Meer PF; Zwaginga JJ
    Transfusion; 2019 Feb; 59(2):470-481. PubMed ID: 30499599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bedside filtration of blood products in the prevention of HLA alloimmunization--a prospective randomized study. Alloimmunisation Study Group.
    Williamson LM; Wimperis JZ; Williamson P; Copplestone JA; Gooi HC; Morgenstern GR; Norfolk DR
    Blood; 1994 May; 83(10):3028-35. PubMed ID: 8180400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization.
    Murphy MF; Metcalfe P; Thomas H; Eve J; Ord J; Lister TA; Waters AH
    Br J Haematol; 1986 Mar; 62(3):529-34. PubMed ID: 3954967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia.
    Schiffer CA; Dutcher JP; Aisner J; Hogge D; Wiernik PH; Reilly JP
    Blood; 1983 Oct; 62(4):815-20. PubMed ID: 6349715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of white blood cell fragments, during the preparation and storage of platelet concentrates, as measured by using real-time polymerase chain reaction.
    Dijkstra-Tiekstra MJ; van der Schoot CE; Pietersz RN; Huijgens PC; van der Meer PF; Reesink HW
    Vox Sang; 2004 Nov; 87(4):250-6. PubMed ID: 15585020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White cell reduction in platelet concentrates and packed red cells by filtration: a multicenter clinical trial. The Trap Study Group.
    Kao KJ; Mickel M; Braine HG; Davis K; Enright H; Gernsheimer T; Gillespie MJ; Kickler TS; Lee EJ; McCullough JJ
    Transfusion; 1995 Jan; 35(1):13-9. PubMed ID: 7998062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients.
    Hogge DE; McConnell M; Jacobson C; Sutherland HJ; Benny WB; Massing BG
    Transfusion; 1995 Aug; 35(8):645-52. PubMed ID: 7631404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractoriness to platelet transfusions in children with acute leukemia.
    DeCoteau J; Haddad S; Blanchette V; Poon A
    J Pediatr Hematol Oncol; 1995 Nov; 17(4):306-10. PubMed ID: 7583385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial.
    Hess JR; Trachtenberg FL; Assmann SF; Triulzi DJ; Kaufman RM; Strauss RG; Granger S; Slichter SJ
    Vox Sang; 2016 Oct; 111(3):281-291. PubMed ID: 27185561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration.
    Andreu G; Dewailly J; Leberre C; Quarre MC; Bidet ML; Tardivel R; Devers L; Lam Y; Soreau E; Boccaccio C
    Blood; 1988 Sep; 72(3):964-9. PubMed ID: 3416079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components.
    Dzieczkowski JS; Barrett BB; Nester D; Campbell M; Cook J; Sugrue M; Andersen JW; Anderson KC
    Transfusion; 1995 Jan; 35(1):20-5. PubMed ID: 7998063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.